U.S. flag

An official website of the United States government

NM_000492.4(CFTR):c.2908G>A (p.Gly970Ser) AND Cystic fibrosis

Germline classification:
Conflicting interpretations of pathogenicity (2 submissions)
Last evaluated:
Apr 10, 2024
Review status:
criteria provided, conflicting classifications
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000673430.2

Allele description [Variation Report for NM_000492.4(CFTR):c.2908G>A (p.Gly970Ser)]

NM_000492.4(CFTR):c.2908G>A (p.Gly970Ser)

Gene:
CFTR:CF transmembrane conductance regulator [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
7q31.2
Genomic location:
Preferred name:
NM_000492.4(CFTR):c.2908G>A (p.Gly970Ser)
HGVS:
  • NC_000007.14:g.117603782G>A
  • NG_016465.4:g.142999G>A
  • NM_000492.4:c.2908G>AMANE SELECT
  • NP_000483.3:p.Gly970Ser
  • NP_000483.3:p.Gly970Ser
  • LRG_663t1:c.2908G>A
  • LRG_663:g.142999G>A
  • LRG_663p1:p.Gly970Ser
  • NC_000007.13:g.117243836G>A
  • NM_000492.3:c.2908G>A
Protein change:
G970S
Links:
dbSNP: rs397508453
NCBI 1000 Genomes Browser:
rs397508453
Molecular consequence:
  • NM_000492.4:c.2908G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Cystic fibrosis (CF)
Synonyms:
Mucoviscidosis
Identifiers:
MONDO: MONDO:0009061; MedGen: C0010674; Orphanet: 586; OMIM: 219700

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000798631Counsyl
criteria provided, single submitter

(Counsyl Autosomal Recessive and X-Linked Classification Criteria (2018))
Uncertain significance
(Mar 21, 2018)
unknownclinical testing

PubMed (1)
[See all records that cite this PMID]

Citation Link,

SCV005076787Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Likely pathogenic
(Apr 10, 2024)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing
not providedunknownunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Spectrum of CFTR gene mutations in Ecuadorian cystic fibrosis patients: the second report of the p.H609R mutation.

Ortiz SC, Aguirre SJ, Flores S, Maldonado C, Mejía J, Salinas L.

Mol Genet Genomic Med. 2017 Nov;5(6):751-757. doi: 10.1002/mgg3.337. Epub 2017 Oct 11.

PubMed [citation]
PMID:
29178639
PMCID:
PMC5702561

Details of each submission

From Counsyl, SCV000798631.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV005076787.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

Variant summary: CFTR c.2908G>A (p.Gly970Ser) results in a non-conservative amino acid change located in the ABC transporter type 1, transmembrane domain (IPR011527) of the encoded protein sequence. Four of four in-silico tools predict a damaging effect of the variant on protein function. This variant also falls within exonic splice region in exon 26. Several computational tools predict a significant impact on normal splicing: Two predict the variant abolishes the canonical 5' splicing donor site. One predict the variant weakens the canonical 5' donor site. One predict the variant no significant impact on splicing. However, these predictions have yet to be confirmed by functional studies. The variant was absent in 251120 control chromosomes. c.2908G>A has been reported in the literature in at-least three individuals affected with Cystic Fibrosis, without detailed information for analysis (Ortiz_2017). These report(s) do not provide unequivocal conclusions about association of the variant with Cystic Fibrosis. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication have been ascertained in the context of this evaluation (PMID: 29178639). ClinVar contains an entry for this variant (Variation ID: 53589). Based on the evidence outlined above, the variant was classified as likely pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Jul 23, 2024